✦ LIBER ✦
Natalizumab long-term therapy for relapsing MS in clinical routine: Final results of the prospective observational multicenter study Tysabri® 24 plus
✍ Scribed by Maeurer, M.; Wiendl, H.; Heesen, C.; Gass, A.; Wernsdoerfer, C.; Kieseier, B.C.; Zingler, V.C.; Wettmershausen, C.
- Book ID
- 122043076
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 62 KB
- Volume
- 333
- Category
- Article
- ISSN
- 0022-510X
No coin nor oath required. For personal study only.